Five Important Questions About Pfizer’s COVID-19 Vaccine

Pfizer’s vaccine consists of genetic material called mRNA encased in tiny particles that shuttle it into our cells. From there, it stimulates the immune system to make antibodies that protect against the virus. A similar strategy is employed in other leading COVID-19 vaccine candidates. If mRNA vaccines can protect against COVID-19 and, presumably, other infectious diseases, it will be a momentous piece of news.

Read More »

Addressing and Extending Psychosocial Care and Support to Patients and HCWs During COVID-19

In the authors’ hospital of practice, patients who required isolation at the hospital had to adhere to strict infection control protocols, and some did not have a readily available caregiver who could room with them. While provisions were made for these patients to receive some of their essential belongings from home such as their gadgets, phones, and toys, many were unable to access them owing to caregiver challenges, giving rise to feelings of isolation and displacement.

Read More »

PSQH: The Podcast Episode 14 – Infection Prevention During a Pandemic

On episode 14 of PSQH: The Podcast, host Jay Kumar talks to LRC Systems founder and CEO Dr. Shailesh Date about how U.S. hospitals have responded to COVID-19, what to expect as we enter flu season, thoughts about a potential vaccine, and the threat of co-infections. This episode is part of PSQH’s celebration of International Infection Prevention Week and is brought to you by Angelini Pharma and GOJO, the inventors of Purell.

Read More »

Mortality Data Supports Placing Seriously Ill Coronavirus Patients on ECMO

The co-authors of the recent research article wrote that the study provides “provisional support” for using ECMO to treat coronavirus patients with acute hypoxemic respiratory failure. “In ECMO-supported patients with COVID-19 and characterized as having ARDS, estimated in-hospital mortality 90 days after ECMO initiation was 38.0%, consistent with previous mortality rates in non-COVID-19 ECMO-supported patients with ARDS and acute respiratory failure.”

Read More »